NAV
9.73(-0.45%)Fund Size (CR)
₹614.49Expense Ratio
0.43Scheme Type
Active FundValue Research
Min. investment
₹1,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1,000Exit Load
0%Return Since Launch
-2.22%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Sanjay Chawla
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 6 October 2025 | 10150.41 | 1.50% | - | 0.41% | 85/920 |
1 Month | 12 September 2025 | 9909.10 | -0.91% | - | 0.30% | 768/916 |
3 Month | 11 July 2025 | 9798.98 | -2.01% | - | 1.34% | 800/880 |
6 Month | - | - | - | - | - | -/- |
1 Year | - | - | - | - | - | -/- |
3 Year | - | - | - | - | - | -/- |
5 Year | - | - | - | - | - | -/- |
Since Inception | 27 June 2025 | 9778.40 | -2.22% | -2.22% | 13.54% | 886/920 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 1 July 2025 | 40,000 | 39740.39 | -0.65% | -0.65% |
3 Year | - | - | - | - | - |
5 Year | - | - | - | - | - |
10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
undefined%
Standard Deviation
2.35%
Beta
0%
Sharpe Ratio
-0.13%
Treynor's Ratio
7.47%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
---|---|---|---|---|---|
Sun Pharma.Inds. | 10.64% | 410000 | 65.37 | Equity | Pharmaceuticals |
Divi's Lab. | 7.64% | 82500 | 46.94 | Equity | Pharmaceuticals |
Mankind Pharma | 7.53% | 190000 | 46.28 | Equity | Pharmaceuticals |
Apollo Hospitals | 6.03% | 50000 | 37.05 | Equity | Healthcare |
Cipla | 5.44% | 222500 | 33.45 | Equity | Pharmaceuticals |
Max Healthcare | 5.44% | 300000 | 33.44 | Equity | Healthcare |
Abbott India | 4.29% | 9000 | 26.36 | Equity | Pharmaceuticals |
Aster DM Health. | 4.08% | 400000 | 25.08 | Equity | Healthcare |
Torrent Pharma. | 3.81% | 65000 | 23.42 | Equity | Pharmaceuticals |
Astrazeneca Phar | 3.33% | 22500 | 20.49 | Equity | Pharmaceuticals |
Peer Comparison
Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
---|---|---|---|---|---|---|---|
Baroda BNP Paribas Health and Wellness Fund-Dir(G) | 614.49 | -0.91% | -2.01% | - | - | - | |
Nippon India Taiwan Equity Fund - Direct (G) | 406.67 | -0.23% | 22.00% | 82.69% | 41.91% | 42.01% | |
Nippon India Taiwan Equity Fund - Direct (IDCW) | 406.67 | -0.23% | 22.00% | 82.69% | 41.91% | 42.01% | |
Aditya Birla SL International Equity Fund - Direct (G) | 266.19 | -0.28% | 7.78% | 28.88% | 26.05% | 19.55% | |
Aditya Birla SL International Equity Fund - Direct (IDCW) | 266.19 | -0.28% | 7.78% | 28.88% | 26.05% | 19.55% | |
Franklin Asian Equity Fund - Direct (G) | 279.13 | 4.59% | 11.90% | 32.68% | 16.44% | 15.74% |
List of Schemes under Baroda BNP Paribas Mutual Fund
News
Baroda BNP Paribas MF announces IDCW & Monthly Income Distribution cum Capital Withdrawal (IDCW) under its scheme
Baroda BNP Paribas Mutual Fund has announced 08 October 2025 as the record date for declaration of IDCW on the face value of Rs 10 per unit under the following scheme. The amount IDCW (Rs. per unit) will be:Baroda BNP Paribas Arbitrage Fund ' Regular Plan ' Monthly IDCW Option & Direct Plan ' Monthly IDCW Option: Rs. 0.06 each
Powered by Capital Market - Live News
Baroda BNP Paribas Mutual Fund announces IDCW Income Distribution cum Capital Withdrawal (IDCW) under its schemes
Baroda BNP Paribas Mutual Fund has announced 29 September 2025 as the record date for declaration of Income Distribution cum Capital Withdrawal (IDCW) in the following schemes. The proposed IDCW on the face value of Rs 10 per unit will be:Baroda BNP Paribas Aggressive Hybrid Fund ' Regular Plan ' IDCW Option: Rs 0.13 per unit.
Baroda BNP Paribas Aggressive Hybrid Fund ' Direct Plan ' IDCW Option: Rs 0.14 per unit
Baroda BNP Paribas Multi Cap Fund ' Regular Plan ' IDCW Option: Rs 0.41 per unit.
Baroda BNP Paribas Multi Cap Fund ' Direct Plan ' IDCW Option: Rs 0.44 per unit.
Powered by Capital Market - Live News
Baroda BNP Paribas Banking and PSU Bond Fund Merger into Baroda BNP Paribas Short Duration Fund
Baroda BNP Paribas Mutual Fund has approved the merger of Baroda BNP Paribas Banking and PSU Bond Fund Merger into Baroda BNP Paribas Short Duration Fund, with effect from 17 October 2025.Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
9 June 2025
Total AUM (Cr)
₹614.49
Baroda BNP Paribas Health and Wellness Fund-Dir(G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Baroda BNP Paribas Mutual Fund. Launched in 9 June 2025, this fund is managed by Sanjay Chawla. With assets under management (AUM) worth ₹614.49 (Cr), as of 14 October 2025, Baroda BNP Paribas Health and Wellness Fund-Dir(G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of -2.22% since its launch.
The current NAV of Baroda BNP Paribas Health and Wellness Fund-Dir(G) is ₹9.73, as on 14 October 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in Baroda BNP Paribas Health and Wellness Fund-Dir(G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹1,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
Redemption/ switch out of units upto 10% of the units allotted before 1 year from date of allotment Exit load NIL. For redemption/switch out of units above 10% of units allotted within 1 year from the date of allotment 1.00% of applicable NAV. For redemption/switch out of units after 1 year from the date of allotment Nil. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 94.77% in Equity, 7.88% in Debt and -2.65% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 67.82% in Pharmaceuticals & Biotech, 19.84% in Healthcare Services, 6.06% in Debt, 2.73% in Insurance, 2.45% in Healthcare Equipment & Su